Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Transplantation of stem cell-derived pancreatic islet cells

A large fraction of patients with diabetes mellitus require insulin treatment to control glucose metabolism; however, this treatment brings risks of hypoglycaemia and provides suboptimal metabolic control. Transplantation of stem cell-derived pancreatic islet cells could be an ideal solution, which is approaching clinical translation.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout


  1. National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes in America 3rd ed (NIH, 2018).

  2. Augsornworawat, P., Maxwell, K. G., Velazco-Cruz, L. & Millman, J. R. Single-cell transcriptome profiling reveals beta cell maturation in stem cell-derived islets after transplantation. Cell Rep. 32, 108067 (2020).

    Article  CAS  Google Scholar 

  3. Ricordi, C. et al. National Institutes of Health-sponsored clinical islet transplantation consortium phase 3 trial: manufacture of a complex cellular product at eight processing facilities. Diabetes 65, 3418–3428 (2016).

    Article  CAS  Google Scholar 

  4. Lablanche, S. et al. Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial. Lancet Diabetes Endocrinol. 6, 527–537 (2018).

    Article  CAS  Google Scholar 

  5. Ricordi, C. et al. Transplanting islet cells can fix brittle diabetes. Why isn’t it available in the U.S.? CellR4 7, e2768 (2019).

    Google Scholar 

  6. D’Amour, K. A. et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 24, 1392–1401 (2006).

    Article  Google Scholar 

  7. Pagliuca, F. W. et al. Generation of functional human pancreatic beta cells in vitro. Cell 159, 428–439 (2014).

    Article  CAS  Google Scholar 

  8. Velazco-Cruz, L. et al. Acquisition of dynamic function in human stem cell-derived beta cells. Stem Cell Reports 12, 351–365 (2019).

    Article  CAS  Google Scholar 

  9. Agulnick, A. D. et al. Insulin-producing endocrine cells differentiated in vitro from human embryonic stem cells function in macroencapsulation devices in vivo. Stem Cells Transl Med. 4, 1214–1222 (2015).

    Article  CAS  Google Scholar 

  10. Millman, J. R. et al. Generation of stem cell-derived beta-cells from patients with type 1 diabetes. Nat. Commun. 7, 11463 (2016).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Camillo Ricordi.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lanzoni, G., Ricordi, C. Transplantation of stem cell-derived pancreatic islet cells. Nat Rev Endocrinol 17, 7–8 (2021).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing